News Focus
News Focus
Followers 88
Posts 3116
Boards Moderated 0
Alias Born 09/07/2014

Re: flipper44 post# 756057

Monday, 03/24/2025 10:37:54 AM

Monday, March 24, 2025 10:37:54 AM

Post# of 828630
This is why I believe the RA is waiting for something to come onboard that will allow NWBO to handle the overload of patients who will want this treatment right away...something....like... EDEN...?
With EDEN our entry into commercialization is likely to be much smoother than without it.
Not saying I want us to wait for EDEN. Just pointing out the obvious.
Also less expensive for MRHA and the UK.

Flipper:

“One thing that bothers me immensely about the process is, that despite the fact the agency knows this technology inside and out, the agency supposedly highly prioritizes this cancer indication, supposedly prioritizes this amazing and unprecedented type of safety profile, know its potential (combos/versions), understand its impact on long term survival, have over a decade experience with the therapy in compassionate treatment, picked through and certified all relevant manufacturing, understand patient need, and despite all that, they’re incredibly slow.

Patients are waiting.”

Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News